Search

Author/Creator Zhang, Jonathan

1. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. (4th November 2015)

Authors:
Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Issue 2 (December 2015)

Authors:
Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗